It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

Background Screening for human papillomavirus (HPV) infection is more effective in
reducing the incidence of cervical cancer than screening using Pap smears. Moreover, HPV …

The accurate diagnosis of human papillomavirus (HPV) causality in oropharyngeal
squamous cell carcinomas (OPSCC) is likely to influence therapeutic decisions in affected …

Introduction Population coverage for cervical cancer screening is an important determinant
explaining differences in the incidence of cervical cancer between countries. Offering …

Cancer management is major concern of health organizations and viral cancers account for
approximately 15.4% of all known human cancers. Due to large number of patients, efficient …

Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and
women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and …

In the early 1900s, numerous seminal publications reported that high rates of cancer
occurred in certain occupations. During this period, work with infectious agents produced …

This study aimed to explore the changes of the vaginal microbiota and enzymes in the
women with high-risk human papillomavirus (HR-HPV) infection and cervical lesions. A total …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Human papillomavirus (HPV) infection is linked with several cancers such as cancer cervix,
vagina, vulva, head and neck, anal, and penile carcinomas. Although there is a proven …